Sometimes, a competitor's results can give more insight into a company's situation. In this case, European Aeronautic Defence & Space Co. NV (EADS) reported a first-quarter loss due to problems with its commercial aircraft division Airbus, the world's biggest planemaker. The Airbus division struggled with delays and rising costs on the A380 superjumbo as well as a weak dollar. It is the third consecutive loss EADS is reporting, although it beat analysts' projected loss.
The Chief Financial Officer of EADS had already told shareholders last week that the Airbus unit is expected to post another "significant" loss this year, but could return to profitability in 2008.
Compare this to Boeing Co.'s (NYSE: BA) first quarter results reported late April, where the company posted a 27% rise in profit, beating analysts estimates. In the first quarter, Boeing booked orders for 185 commercial planes, beating Airbus by 51, and it increased shipments of the 737, its best-selling model, by 15%.
Also, orders for Boeing's new fuel-efficient 787 are soaring with over 500 orders; it is the company's most successful aircraft introduction ever. Airbus will not have an answer in time, meaning Boeing might regain the lead in commercial aviation next year. Airbus's answer, the A350 XWB, will only enter service five years after the 787 begins commercial service in 2008.
Boeing just keeps looking better.
Last updated: February 09, 2010: 11:01 PM
Hot Stocks
DailyFinance Headlines
- Disney Reports Flat Earnings But Sees Conditions Improving
- Google's Bad Buzz: Microsoft, Yahoo Mock New Social Product
- Paulson Predicts U.S. Will Recover 'Every Penny' of Bank Bailout Cash
- The Dow's Jump Doesn't Mean All's Well in Europe
- Hermes Opens Store Just for Men
TheFlyOnTheWall.com Headlines
- Papa John's is the investment choice of the big three players, Barrons.com says
- Coca-Cola's should continue to offer investors sweet returns, Barrons.com says
- Jim Cramer's "Mad Money"
- Terreno Realty 8.75M share IPO priced at $20.00
- MGP Ingredients, Inc. reports Q2 EPS 28c vs. consensus of 19c
BioHealth Investor Headlines
- Cell Therapeutics Facing Tougher FDA (CTIC)
- New Restless Leg Syndrome Review for XenoPort (XNPT, GSK)
- AMAG Fights Back (AMAG)
- Human Genome Sciences… When Insiders Sell Stock (HGSI)
- 10-Bagger Hunt Heads Back to Repros (RPRX)
WalletPop Headlines
- Borders coupon for 33% off
- No seed shortage for gardeners this spring, despite reports to the contrary
- Deaths spark crib recall: CSPC says to stop using Generation 2 and ChildESIGNS cribs
- Survey says? Homeowners think real estate collapse is over
- Dave Ramsey's recession-themed pick-up lines
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Money
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Dow Jones Industrial Average
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
- Zhu Zhu Pets
- Small Business Checking Account
- Crib Recall


